Related Experiment Video
Updated: Oct 29, 2025

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
p53 deficiency induces MTHFD2 transcription to promote cell proliferation and restrain DNA damage
Abstract:
Cancer cells acquire metabolic reprogramming to satisfy their high biogenetic demands, but little is known about how metabolic remodeling enables cancer cells to survive stress associated with genomic instability. Here, we show that the mitochondrial methylenetetrahydrofolate dehydrogenase (MTHFD2) is transcriptionally suppressed by p53, and its up-regulation by p53 inactivation leads to increased folate metabolism, de novo purine synthesis, and tumor growth in vivo and in vitro. Moreover, MTHFD2 unexpectedly promotes nonhomologous end joining in response to DNA damage by forming a complex with PARP3 to enhance its ribosylation, and the introduction of a PARP3-binding but enzymatically inactive MTHFD2 mutant (e.g., D155A) sufficiently prevents DNA damage. Notably, MTHFD2 depletion strongly restrains p53-deficient cell proliferation and sensitizes cells to chemotherapeutic agents, indicating a potential role for MTHFD2 depletion in the treatment of p53-deficient tumors.
Insights
The study reveals methylenetetrahydrofolate dehydrogenase (MTHFD2) promotes cancer growth by aiding DNA repair in p53-deficient cells. Depleting MTHFD2 may offer a new treatment strategy for these tumors.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Cancer cells exhibit metabolic reprogramming to meet high biosynthetic demands.
- The role of metabolic remodeling in cancer cell survival under genomic instability is not well understood.
Purpose of the Study:
- To investigate the role of methylenetetrahydrofolate dehydrogenase (MTHFD2) in p53-deficient cancer cells.
- To explore MTHFD2's function in DNA damage repair and its implications for tumor growth and treatment.
Main Methods:
- Analysis of MTHFD2 transcriptional regulation by p53.
- Assessment of folate metabolism and de novo purine synthesis.
- Investigation of MTHFD2's interaction with PARP3 in DNA repair.
- Evaluation of MTHFD2 depletion effects on cell proliferation and chemosensitivity.
Main Results:
- MTHFD2 is transcriptionally suppressed by p53; its upregulation upon p53 inactivation increases folate metabolism, purine synthesis, and tumor growth.
- MTHFD2 promotes nonhomologous end joining DNA repair by complexing with PARP3.
- An inactive MTHFD2 mutant disrupts this DNA repair function.
- MTHFD2 depletion inhibits p53-deficient cell proliferation and enhances sensitivity to chemotherapy.
Conclusions:
- MTHFD2 plays a critical role in supporting p53-deficient tumor growth and survival through enhanced metabolism and DNA repair.
- Targeting MTHFD2 represents a potential therapeutic strategy for p53-deficient cancers.
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Inhibition of Cdk Activity

